SlideShare a Scribd company logo
Circ J 2006; 70: 304 – 310



 Utility of Second Derivative of the Finger Photoplethysmogram
   for the Estimation of the Risk of Coronary Heart Disease
                    in the General Population

            Toshiaki Otsuka, MD; Tomoyuki Kawada, MD; Masao Katsumata, PhD; Chikao Ibuki, MD*


      Background Increased arterial stiffness has been shown to be associated with coronary heart disease (CHD).
      However, it remains unclear as to whether the second derivative of the finger photoplethysmogram (SDPTG), a
      non-invasive method for the assessment of arterial stiffness, is useful for the estimation of risk of CHD in the
      general population.
      Methods and Results The SDPTG in 211 subjects (age: 63±15 years, range: 21–91 years, 93 males) was
      recorded without apparent atherosclerotic disorders from a community. The relationship between the SDPTG
      indices (b/a and d/a) and coronary risk factors (n=211) or the Framingham risk score (n=158, age: 60±12 years,
      range: 30–74 years, 63 males) were analyzed. The SDPTG indices significantly correlated with the Framingham
      risk score in both genders (b/a; rmale =0.43, rfemale =0.54 and d/a; rmale =–0.38, rfemale =–0.58), as well as several
      coronary risk factors. In the receiver operating characteristics curve analyses, the b/a discriminated high-risk sub-
      jects for CHD, who were in the highest quintile of the Framingham risk score in each gender, with a sensitivity
      and specificity of 0.85 and 0.58 in males and 0.83 and 0.72 in females, respectively.
      Conclusions These results suggest that the SDPTG is useful for the estimation of risk of CHD in the general
      population. (Circ J 2006; 70: 304 – 310)
      Key Words: Arterial stiffness; Cardiovascular preventive medicine; Coronary heart disease; Framingham risk
                 score; Second derivative of the finger photoplethysmogram




C
         oronary heart disease (CHD) is still one of the             index (AIx).19,21 In addition, the SDPTG indices were inde-
                                           1
          major causes of deaths in Japan. Moreover, CHD             pendently influenced by several risk factors for atheroscle-
          mortality is expected to increase in the near future       rosis in patients with hypertension23 and in the general
because the lifestyles of the Japanese, such as their dietary                   24
                                                                     population. However, it is still unclear as to whether the
                                      2
habits, have become westernized. Indeed, it has been                 SDPTG indices are related to the coronary risk factors, or
reported that young Japanese patients with CHD who have              moreover, the risk for the future development of CHD in
multiple coronary risk factors, including hypertension,              apparently healthy individuals.
hyperlipidemia, and obesity, all of which might be associ-              Thus, we conducted a cross-sectional study in a Japanese
                                                  3
ated with their lifestyles, have been increasing. Therefore,         community to assess the relationship between the SDPTG
it is important in the field of cardiovascular preventive            indices and coronary risk factors in subjects with no appar-
medicine to identify those at risk of CHD in general popu-           ent atherosclerotic disorders. Furthermore, we calculated
lations.                                                                                          26
                                                                     the Framingham risk score, which has been used to esti-
   Increased arterial stiffness has been shown to be associ-         mate an individual’s risk of CHD, and determined the
                                                  4–11
ated not only with several coronary risk factors, but also           optimal cut-off points of the SDPTG indices to discrimi-
with the future development of CHD.       12–18 Recently, the        nate individuals at risk of CHD.
second derivative of the finger photoplethysmogram
(SDPTG) has been developed as one of the non-invasive
and convenient methods for pulse-wave analysis.      19–21 The                               Methods
SDPTG is obtained from double differentiation of the                 Study Population
finger photoplethysmogram (PTG) and is thought to pro-                   In the present study, 211 subjects (age: 63±15 years,
vide structural and functional properties of both central and        range: 21–91 years, 93 males) who underwent both SDPTG
                    19
peripheral arteries. Indeed, an index calculated from the            recording and blood sampling after an overnight fast were
SDPTG showed a significant association with age,       19,20,22–24    recruited from the annual health examination in a commu-
                               25
carotid arterial distensibility, and the aortic augmentation         nity, Yamanashi, Japan, in 2004 and 2005. Subjects with a
                                                                     history or presence of atherosclerotic disorders, such as
(Received July 1, 2005; revised manuscript received December 12,     CHD, stroke, and peripheral obstructive arterial disease,
2005; accepted December 19, 2005)                                    were excluded from the study. We also excluded subjects
Environmental Medicine, Graduate School of Medicine, *Department     with renal dysfunction (serum creatinine ≥1.3 mg/dl) or
of Internal Medicine and Cardiology, Tama-Nagayama Hospital,
Nippon Medical School, Tokyo, Japan
                                                                     patients who had taken medications for hypertension,
Mailing address: Toshiaki Otsuka, MD, Environmental Medicine,        hyperlipidemia, or diabetes mellitus. Subjects with abnor-
Graduate School of Medicine, Nippon Medical School, 1-1-5 Sendagi,   mal Q-waves on the 12-lead electrocardiogram at rest were
Bunkyo-ku, Tokyo 113-8603, Japan. E-mail: otsuka@nms.ac.jp           also excluded. This study protocol was approved by the

                                                                                             Circulation Journal Vol.70, March 2006
SDPTG and Risk of CHD                                                                                                                             305

                                                                           Table 1 Clinical Characteristics and SDPTG Indices of Study
                                                                           Subjects (n=211)

                                                                             Parameters
                                                                             Age (years)                                              63±15
                                                                               <40                                                  20 (9.5%)
                                                                               40–49                                                18 (8.5%)
                                                                               50–59                                                34 (16.1%)
                                                                               60–69                                                56 (26.5%)
                                                                               70–79                                                65 (30.8%)
                                                                               ≥80                                                  18 (8.6%)
                                                                             Male gender                                            93 (44.1%)
                                                                             BMI (kg/m2)                                            22.6±3.1
                                                                             SBP (mmHg)                                              130±18
                                                                             DBP (mmHg)                                               76±12
                                                                             PP (mmHg)                                                54±12
                                                                             TC (mg/dl)                                              199±37
                                                                             TG (mg/dl)                                               96±72
                                                                             HDLC (mg/dl)                                             59±16
                                                                             TC/HDLC ratio                                           3.6±1.1
                                                                             FPG (mg/dl)                                              93±11
                                                                             Hypertension                                           59 (28.0%)
                                                                             Hyperlipidemia                                         65 (30.8%)
Fig 1. A schema of the finger photoplethysmogram (PTG, Top) and               Obesity                                                39 (18.5%)
the second derivative of the finger photoplethysmogram (SDPTG,                Diabetes mellitus                                       0 (0%)
Bottom). The SDPTG consists of 5 waves and each wave is consecu-             Smoking                                                23 (16.3%)
tively named ‘a’, ‘b’, ‘c’, ‘d’, and ‘e’ wave, respectively. The ‘a’ and     SDPTG indices
‘b’ waves are included in the early systolic phase and the ‘c’ and ‘d’         b/a                                                 –0.46±0.14
waves in the late systolic phase of the PTG.                                   d/a                                                 –0.36±0.13

                                                                           Presented values are the mean ± SD or number of subjects (percent of total).
                                                                           Hypertension was defined as SBP ≥140 mmHg and/or DBP ≥90 mmHg.
                                                                           Hyperlipidemia was defined as TC ≥220 mg/dl and/or TG ≥150 mmHg.
ethics committee of Nippon Medical School. Written                         Obesity was defined as BMI ≥25 kg/m2. Diabetes mellitus was defined as
informed consent was obtained from all participants.                       FPG ≥140 mg/dl. Smoking was defined as regularly smoking during the
                                                                           previous 12 months.
Measurements of the Data                                                   SDPTG, second derivative of the finger photoplethysmogram; BMI, body
   Blood sampling and hemodynamic measurements were                        mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure;
conducted in a temperature-controlled room maintained at                   PP, pulse pressure; TC, total cholesterol; TG, triglycerides; HDLC, high-
                                                                           density lipoprotein cholesterol; FPG, fasting plasma glucose.
24±2°C. Blood samples were collected from the antecu-
bital vein in each participant after an overnight fast. Serum
total cholesterol (TC), triglycerides, and plasma glucose
were measured by enzymatic reference methods on an                         phase of the PTG, whereas the ‘c’ and ‘d’ waves are in-
automated analyzer. Serum high-density lipoprotein cho-                    cluded in the late systolic phase. The height of each wave
lesterol (HDLC) was analyzed using a direct method based                   from the baseline was measured and the ratios of the height
on the selective solubilizing effect. Systolic blood pressure              of the ‘a’ wave to that of the ‘b’ and ‘d’ waves (b/a and d/a)
(SBP) and diastolic blood pressure (DBP) were measured                     were calculated and used as the SDPTG indices in the pres-
by means of an automated oscillometric device (USM-                        ent study.
700GSi, Elquest Corporation, Chiba, Japan), after the
subject had been resting for at least 5 min in a sitting posi-             Assessment of Individual’s CHD Risk Level
tion. Pulse pressure (PP) was defined as the difference                       In 158 subjects who were aged 30 to 74 years (mean age:
between the SBP and DBP. The SDPTG was recorded in                         60±12 years, 63 males), the individual’s CHD risk level
the supine position using an SDP-100 instrument (Fukuda                    was estimated based on the Framingham CHD score sheets
Denshi, Tokyo, Japan), when the subject had been resting                                                 26
                                                                           presented by Wilson et al. This scoring system was
for at least 5 min in the same position. A transducer was                  applied only to subjects with an age ranging from 30 to 74
placed on the cuticle of the index finger of the left hand and              years; therefore, 45 subjects over the age of 75 and 8 sub-
the signal of the blood volume changes in the peripheral                   jects under the age of 30 were excluded from this assess-
circulation, which indicated PTG, was sent to the SDP-100.                 ment. The details of the algorithm for the determination of
The PTG describes the changes in the absorption of light                                                                      26
                                                                           the risk score are described in the original report. In brief,
by hemoglobin using a waveform according to the Lambert-                   6 risk factors (age, gender, blood pressure, cholesterol
          27
Beer law. The details of the methodology for the measure-                  value, smoking status, and presence or absence of diabetes)
ment of the PTG and the SDPTG are described elsewhere.      28             were changed into the respective scores and the total score
The double differentiation of the PTG was then performed                   was used as the individual’s CHD risk level. Diabetes was
automatically in the device. The reproducibility of the                    defined as fasting plasma glucose (FPG) ≥140 mg/dl in the
SDPTG has been previously reported with an intraobserver                                  26
                                                                           original report, and we used the same criterion in the pres-
                    22
repeatability of 8%, according to Bland and Altman.     29                 ent study. Since subjects who were in the highest quintile
   A schema of the PTG and SDPTG is shown in Fig 1. The                    of the Framingham risk score could be regarded as ‘rela-
SDPTG consists of 4 waves in systole (‘a’, ‘b’, ‘c’, and ‘d’               tively’ high-risk for CHD in a population, we defined them
waves) and 1 wave in diastole (‘e’ wave). The ‘a’ and ‘b’                  as high-risk subjects in each gender in the present study.
waves on the SDPTG are included in the early systolic

Circulation Journal Vol.70, March 2006
306                                                                                                                               OTSUKA T et al.

          Table 2 Relationship Between the SDPTG Indices (b/a and d/a) and the Coronary Risk Factors
                                                           Pearson’s correlation                    Multiple linear
                                                                coefficient                       regression analysis
                                                              r           p value                          t            p value
             b/a
               Age                                          0.52          <0.001           0.45          7.49           <0.001
               Gender (Female=0, Male=1)                   –0.24          <0.001          –0.25         –4.27           <0.001
               BMI                                          0.03           0.67             –
               SBP                                          0.24          <0.001           0.15          2.49           <0.05
               DBP                                          0.10           0.14             –
               PP                                           0.26          <0.001            N
               TC                                           0.01           0.84             –
               TG                                           0.03           0.64             –
               HDLC                                        –0.09           0.18             –
               TC/HDLC ratio                                0.11           0.10             –
               FPG                                          0.13           0.06             –
               Smoking (No=0, Yes=1)                       –0.09           0.21             –
                                                                                                                 (model R2 =0.33)
             d/a
               Age                                         –0.51          <0.001          –0.43         –6.60           <0.001
               Gender (Female=0, Male=1)                    0.08           0.26             –
               BMI                                         –0.02           0.79             –
               SBP                                         –0.26          <0.001          –0.09         –1.38            0.17
               DBP                                         –0.19          <0.01             N
               PP                                          –0.21          <0.01             N
               TC                                          –0.06           0.41             –
               TG                                           0.00           0.99             –
               HDLC                                        –0.10           0.15             –
               TC/HDLC ratio                               –0.15          <0.05           –0.04         –0.59            0.55
               FPG                                         –0.28          <0.001          –0.11         –1.78            0.08
               Smoking (No=0, Yes=1)                        0.07           0.30             –
                                                                                                                 (model R2 =0.28)

          N, not included in the model. Other abbreviations see in Table 1.


Statistical Analysis                                                           as a marker for the discrimination of the high-risk subjects
   Continuous variables and categorical data were expressed                    for CHD. The point on the ROC curve closest to the upper
as the mean ± SD and the number of subjects (with a per-                       left-hand corner was defined as the optimal cut-off point.
centage), respectively. Statistical analyses were performed                    All statistical tests were 2-sided and a p-value less than
by using Dr. SPSS II software (version 11.0.1J, SPSS Japan,                    0.05 was considered to be significant.
Tokyo, Japan) for Windows. The relationship between the
SDPTG indices and the coronary risk factors or the Fram-
ingham risk score was assessed by means of Pearson’s                                                       Results
moment correlation coefficient. Thereafter, multiple linear                     Clinical Characteristics and SDPTG Indices of the Study
regression analyses were performed with the SDPTG                              Subjects
indices as dependent variables and the coronary risk factors                      The clinical characteristics and the SDPTG indices of
that showed significance with Pearson’s moment correla-                         the study subjects are shown in Table 1. The majority of
tion coefficient as independent variables (except for DBP                       subjects were in the age range of 70 to 79 years. The mean
and PP because of a high correlation with SBP). To evalu-                      body mass index, SBP, DBP, serum lipid levels, and FPG
ate as to whether the SDPTG indices were associated with                       were within normal range. The prevalence of hypertension
the Framingham risk score independent of age, multiple                         and hyperlipidemia was approximately 30%. None of the
linear regression analyses were conducted with the Fram-                       subjects with diabetes participated in the present study.
ingham risk score as dependent variables and age and the
SDPTG indices as independent variables. Differences in                         SDPTG Indices and Coronary Risk Factors
the coronary risk factors contributing to the Framingham                          The relationships between the SDPTG indices and coro-
risk score (age, SBP, DBP, TC, HDLC, and smoking status)                       nary risk factors are noted in Table 2. The b/a showed a
and the SDPTG indices in each quintile were analyzed                           significant correlation with age, gender, SBP, and PP. The
using one-way analysis of variance (ANOVA) or a chi-                           d/a significantly correlated with age, SBP, DBP, PP,
square test. Post-hoc Dunnett’s tests were performed with                      TC/HDLC ratio, and FPG. In the multiple linear regression
the highest quintile as the control group if the ANOVA                         analyses, the independent variables influencing the b/a
showed significance. To assess the sensitivity, specificity,                     were age, gender, and SBP, whereas only age indepen-
and corresponding cut-off values of the SDPTG indices to                       dently influenced the d/a.
discriminate the high-risk subjects for CHD, analyses of
the receiver operating characteristic (ROC) curves were                        Framingham Risk Score and SDPTG Indices
performed. Significance was assumed when the lower                               The mean Framingham risk score was 5.8±3.4 in males
bound of the 95% confidence interval (CI) of the area under                     and 4.8±5.4 in females. The score was distributed more
the ROC curve (AUC) exceeded 0.5. When the AUC was                             widely in females (–14–16) than in males (–3–13). The
significant, the corresponding SDPTG index was identified                        correlations between the Framingham risk score and the

                                                                                                         Circulation Journal Vol.70, March 2006
SDPTG and Risk of CHD                                                                                                                            307




                                                                                                           Fig 2. Correlations between second deriva-
                                                                                                           tive of the finger photoplethysmogram
                                                                                                           indices and the Framingham risk score in
                                                                                                           each gender. The b/a was positively corre-
                                                                                                           lated (Top), whereas the d/a inversely
                                                                                                           correlated (Bottom) with the Framingham
                                                                                                           risk score in both genders.


           Table 3 Coronary Risk Factors Contributing to the Framingham Risk Score and SDPTG Indices Based on the Quintile
           of the Score
                                                              Quintile of the Framingham risk score                          p value
                                               Q1              Q2              Q3              Q4              Q5           for trend

             Male                           (–3–2)           (3–4)           (5–6)           (7–8)            (9–13)
              Number                           10              11              16              13               13
              Age (years)                    42±9§           52±9§           61±10           66±4             68±7          <0.001
              SBP (mmHg)                   124±12§          128±22†         123±12§         134±18*          152±13         <0.001
              DBP (mmHg)                     75±11*          78±15           73±12†          81±7             89±11         <0.01
              TC (mg/dl)                   198±20          184±43           186±33          196±46           208±30          0.44
              HDLC (mg/dl)                   62±8*           63±18*          57±15           53±22            45±7          <0.05
              Smoking (Yes/No)                2/8             6/5             8/8             4/9              5/8           0.44
              b/a                         –0.64±0.08†     –0.55±0.11      –0.53±0.18      –0.45±0.11       –0.46±0.11       <0.001
              d/a                         –0.25±0.07†     –0.33±0.08      –0.36±0.12      –0.37±0.14       –0.40±0.12       <0.001
             Female                        (–14–1)           (2–4)           (5–6)           (7–9)           (10–16)
               Number                          17              20              21              20               17
               Age (years)                   43±7§           60±7*           66±6            66±7             67±7          <0.001
               SBP (mmHg)                  115±11§          113±10§         121±10§         133±14          140±17          <0.001
               DBP (mmHg)                    73±9            68±9†           69±6†           75±11            79±11         <0.01
               TC (mg/dl)                  200±40          213±31           209±26          211±33           204±45          0.79
               HDLC (mg/dl)                  70±14§          74±13§          66±17§          58±11†           43±9          <0.001
               Smoking (Yes/No)               1/16            0/20            0/21            2/18             2/15          0.33
               b/a                        –0.54±0.11§     –0.47±0.14*     –0.39±0.09      –0.40±0.12       –0.36±0.11       <0.001
               d/a                        –0.26±0.07§     –0.33±0.11†     –0.40±0.09      –0.44±0.09       –0.44±0.11       <0.001

           Presented values are the mean ± SD or number of subjects.
           The range of the Framingham risk score in each quintile is shown in the parentheses.
           §p<0.001, †p<0.01,  and *p<0.05 vs the corresponding values in Q5. See Table 1 for abbreviations.



SDPTG indices in each gender are shown in Fig 2. In both                       sion analysis, such associations were still observed inde-
genders, the b/a positively correlated with the Framingham                     pendently of age in females (b/a; =0.32, p<0.01, d/a; =
risk score (rmale =0.43 and rfemale =0.54, both p<0.001) and                   –0.27, p<0.001), but not in males (b/a; =0.08, d/a; =
the d/a showed a negative correlation (rmale =–0.38, p<0.01                    –0.02).
and rfemale =–0.58, p<0.001). In the multiple linear regres-

Circulation Journal Vol.70, March 2006
308                                                                                                                              OTSUKA T et al.

                                                                         Table 4 Ability of the SDPTG Indices to Discriminate High-Risk
                                                                         Subjects for CHD

                                                                                        Cut-off value    Sensitivity   Specificity   Accuracy
                                                                           Male
                                                                             b/a           –0.53            0.85          0.58         0.64
                                                                           Female
                                                                             b/a           –0.40            0.83          0.72         0.74
                                                                             d/a           –0.39            0.59          0.60         0.60

                                                                         CHD, coronary heart disease. Other abbreviation see in Table 1.



                                                                         Those of the b/a and d/a in females were 0.73 (95% CI:
                                                                         0.60–0.86) and 0.68 (95% CI: 0.56–0.80), respectively. In
                                                                         regard to the d/a in males, the AUC (0.65, 95% CI: 0.49–
                                                                         0.81) did not show significance; therefore, its discrimina-
                                                                         tory ability and corresponding cut-off point were not
                                                                         analyzed. The sensitivity, specificity, and the accuracy for
                                                                         the discrimination of the high-risk subjects for CHD and
                                                                         the corresponding cut-off values are noted in Table 4. The
                                                                         b/a showed discriminatory performance with a sensitivity
                                                                         and specificity of more than 0.8 and 0.7 in females, and
                                                                         more than 0.8 and approximately 0.6 in males, respective-
                                                                         ly. However, both the sensitivity and specificity of the d/a
                                                                         in females were approximately 0.6. The accuracy of these
                                                                         indices ranged from 0.60 to 0.74.

                                                                                                        Discussion
                                                                            The present study showed that the SDPTG indices inde-
                                                                         pendently associated with several coronary risk factors and
                                                                         significantly correlated with the Framingham risk score.
                                                                         Moreover, we found that the b/a, one of the SDPTG indices,
                                                                         might contribute to the discrimination of the high-risk sub-
                                                                         jects for CHD with an acceptable sensitivity and specificity
Fig 3. Receiver operating characteristic (ROC) curves of the second      in the general population. These observations suggest that
derivative of the finger photoplethysmogram indices for the discrimi-     the SDPTG indices reflect the risk of CHD and that the
nation of high-risk subjects for coronary heart disease in males (Top)   measurement of these indices might be useful in terms of
and in females (Bottom). The 95% confidence interval of the area          cardiovascular preventive medicine.
under the ROC curve (AUC) are shown in the parentheses. The b/a in          Several investigators have studied the physiological
both genders and the d/a in females revealed significant discrimina-
tory performance.                                                        meanings and clinical implications of the SDPTG wave-
                                                                         form.19–21,25 The ‘b’ wave on the SDPTG mainly expresses
                                                                         the first vascular response to blood ejection from the left
Coronary Risk Factors and SDPTG Indices in Each                          ventricle and no reflected components from the periphery
Quintile                                                                 interfere. Imanaga et al reported the relationship between
   The subjects who showed a Framingham risk score of                    the b/a and the distensibility of the carotid artery, suggest-
9 or more points in males (n=13) and 10 or more points in                                                                         25
                                                                         ing that the b/a reflects the stiffness of large arteries. In
females (n=17) were classified into the highest quintile and              contrast, the ‘d’ wave mainly represents the intensity of the
were considered to be high-risk subjects for CHD. The                    reflection wave from the periphery, which is determined by
SDPTG indices and the coronary risk factors contributing                 the functional vascular tension and arteriolosclerosis in the
to the calculation of the risk score (except for diabetes) in            peripheral circulation, thus indicating vascular resistance.
each quintile are listed in Table 3. Although TC and smok-               Indeed, Takazawa et al reported that the d/a significantly
ing did not show a difference in the quintiles, age, SBP,                correlated with the aortic AIx, which partially suggests
DBP, and HDLC in the lowest and/or second quintile(s)                    peripheral vascular resistance.  19,21,30 The d/a, therefore,
were significantly lower (or higher) than those parameters                might represent such vascular properties.
in the highest quintile in both genders. In regard to the                   In the present study, the b/a was positively associated
SDPTG indices, both the b/a and d/a in the lowest quintile               with age whereas the d/a was inversely associated with
in males and the lowest and second quintiles in females                  age. Aging increases both large arterial stiffness and vas-
were significantly different from those in the highest quin-                               31
                                                                         cular resistance. These results, therefore, suggest that an
tile.                                                                    elevated b/a and a reduced d/a on the SDPTG reflect an
                                                                         increase in large arterial stiffness and peripheral vascular
Discrimination of High-Risk Subjects for CHD                             resistance, respectively. In multivariate analyses, however,
   The ROC curves of the SDPTG indices to discriminate                   SBP was an independent determinant of the b/a, but not the
the high-risk subjects in each gender are described in Fig 3.            d/a. Moreover, gender was also an independent determi-
The AUC of the b/a in males was 0.69 (95% CI: 0.54–0.84).                nant of the b/a, whereas there was no relationship between

                                                                                                        Circulation Journal Vol.70, March 2006
SDPTG and Risk of CHD                                                                                                                      309

gender and the d/a, even in univariate analysis. Recently,          Third, the number of subjects that participated in the pres-
Hashimoto et al reported significant associations of both            ent study was small for an epidemiological survey. In this
SBP and gender with the d/a, as well as the b/a in the gen-         regard, the smaller number of male participants might have
                  24
eral population. Although precise reasons for this in-              resulted in a lower specificity of the b/a and the lack of
consistency are not clear, one possibility is that the number       discriminatory ability of the d/a, as well as the lack of asso-
of subjects that participated in the present study was              ciations between the SDPTG indices and the Framingham
smaller than that in the study by Hashimoto et al.    24            risk score independent of age, in males. Regardless of these
   It is beyond doubt that a comprehensive risk assessment          limitations, we believe that the present study deserves to
in each individual for the future development of CHD is             report as the first study, to our knowledge, concerning the
important for the primary prevention of cardiovascular              association between the SDPTG and the risk of CHD in the
         32
disease. Therefore, the Framingham risk score has been              general population.
developed as one of the appropriate tools of the compre-               In conclusion, the SDPTG indices significantly associ-
hensive risk assessment of CHD in the USA. Recently,26              ated not only with several coronary risk factors, but also
Suka et al reported that the incidence of CHD gradually             with the Framingham risk score in subjects without appar-
increased with an increase in the Framingham risk score in          ent atherosclerotic disorders at the time of health examina-
                             33
the Japanese population. These observations indicate that           tion. Furthermore, the b/a screened subjects at risk of CHD
this score is applicable to the estimation of the individual’s      with an acceptable sensitivity and specificity. These results
CHD risk in Japan. Meanwhile, numerous studies have                 suggest that the measurement of SDPTG is useful for the
reported that the pulse-wave velocity (PWV), AIx, and PP,           estimation of the risk of CHD in the general population.
all of which are major surrogate markers of arterial stiff-         However, further studies with a larger number of partici-
ness, are associated with cardiovascular risk4–11 and inde-         pants are needed to confirm these results.
pendently predict mortality and morbidity from CHD.         12–18
Furthermore, Yamashina et al recently showed that an                                          Acknowledgments
increased brachial-ankle PWV was an independent deter-                We are thankful to Dr Masakazu Takahashi and the colleagues in our
minant of moderate- to high-risk subjects for CHD based             department for their cooperation in collecting the data.
on the Framingham risk score in Japanese subjects. Their  4
report indicates an association between arterial stiffness                                        References
and the Framingham risk score in the Japanese population.
                                                                     1. Health and Welfare Statistics Association. Trend of National Health.
In the present study, the SDPTG indices significantly corre-             Journal of Health and Welfare Statistics 2004; 51: 49 – 50 (in Japa-
lated with the Framingham risk score. Moreover, there                   nese).
were significant differences in the SDPTG indices in the              2. Egusa G, Yamane K. Lifestyle, serum lipids and coronary artery dis-
highest and other quintiles of the Framingham risk score.               ease: Comparison of Japan with the United States. J Atheroscler
                                                                        Thromb 2004; 11: 304 – 312.
These findings suggest that the measurement of SDPTG                  3. Imamura H, Izawa A, Kai R, Yokoseki O, Uchikawa S, Yazaki Y, et
has utility for the assessment of an individual’s CHD risk in           al. Trends over the last 20 years in the clinical background of young
the general population in Japan. However, significant asso-              Japanese patients with coronary artery disease. Circ J 2004; 68:
ciations between the SDPTG indices and the Framingham                   186 – 191.
                                                                     4. Yamashina A, Tomiyama H, Arai T, Hirose K, Koji Y, Hirayama Y,
risk score were observed independently of age in females,               et al. Brachial-ankle pulse wave velocity as a marker of atherosclero-
but not in males. These findings suggest that age is a con-              tic vascular damage and cardiovascular risk. Hypertens Res 2003;
founding factor for the correlations in males. This point               26: 615 – 622.
should be evaluated more precisely in further studies.               5. Tomiyama H, Yamashina A, Arai T, Hirose K, Koji Y, Chikamori T,
   We were able to determine the optimal cut-off points of              et al. Influences of age and gender on results of noninvasive brachial-
                                                                        ankle pulse wave velocity measurement – a survey of 12517 subjects.
the b/a on the ROC curves to discriminate the high-risk                 Atherosclerosis 2003; 166: 303 – 309.
subjects for CHD in our study population with a sensitivity          6. Taquet A, Bonithon-Kopp C, Simon A, Levenson J, Scarabin Y,
of more than 0.8 in both genders and a specificity of more               Malmejac A, et al. Relations of cardiovascular risk factors to aortic
than 0.7 in females. However, the specificity of the b/a in              pulse wave velocity in asymptomatic middle-aged women. Eur J
                                                                        Epidemiol 1993; 9: 298 – 306.
males was lower than that in females. Reduced specificity             7. Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse
indicates an increase in the number of false positives. How-            wave velocity as a marker of cardiovascular risk in hypertensive pa-
ever, false positives would, at first, be subjected to lifestyle         tients. Hypertension 1999; 33: 1111 – 1117.
modification in terms of the primary prevention of CHD.         32    8. Benetos A, Adamopoulos C, Bureau JM, Temmar M, Labat C, Bean
                                                                        K, et al. Determinants of accelerated progression of arterial stiffness
Therefore, we believe that a higher number of false posi-               in normotensive subjects and in treated hypertensive subjects over a
tives with a specificity of 0.58 in males is acceptable, and             6-year period. Circulation 2002; 105: 1202 – 1207.
the b/a could be used for screening subjects at risk of CHD          9. Hayashi T, Nakayama Y, Tsumura K, Yoshimaru K, Ueda H. Reflec-
in the general population. In contrast, the d/a discriminated           tion in the arterial system and the risk of coronary heart disease. Am J
                                                                        Hypertens 2002; 15: 405 – 409.
high-risk females with a sensitivity and specificity of ap-          10. Nurnberger J, Keflioglu-Scheiber A, Opazo Saez AM, Wenzel RR,
proximately 0.6 and it did not discriminate high-risk males.            Philipp T, Schafers RF. Augmentation index is associated with car-
These findings indicate that the d/a might be less useful for            diovascular risk. J Hypertens 2002; 20: 2407 – 2414.
screening subjects at risk for CHD in the general popula-           11. Weber T, Auer J, O’Rourke MF, Kvas E, Lassnig E, Berent R, et al.
tion.                                                                   Arterial stiffness, wave reflections, and the risk of coronary artery
                                                                        disease. Circulation 2004; 109: 184 – 189.
   The present study has some limitations. First, none of           12. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et
the subjects with diabetes participated in this study. Further          al. Aortic stiffness is an independent predictor of all-cause and car-
studies are needed in populations with glucose intolerance              diovascular mortality in hypertensive patients. Hypertension 2001;
similar to the average Japanese population. Second, this                37: 1236 – 1241.
                                                                    13. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London
study is not a longitudinal survey, but a cross-sectional sur-          GM. Impact of aortic stiffness on survival in end-stage renal disease.
vey. It is, therefore, still uncertain as to whether the SDPTG          Circulation 1999; 99: 2434 – 2439.
indices truly predict mortality and morbidity from CHD.             14. Meaume S, Benetos A, Henry OF, Rudnichi A, Safar ME. Aortic


Circulation Journal Vol.70, March 2006
310                                                                                                                                   OTSUKA T et al.

      pulse wave velocity predicts cardiovascular mortality in subjects >70           photoplethysmogram in treated hypertensive patients: Their relation-
      years of age. Arterioscler Thromb Vasc Biol 2001; 21: 2046 – 2050.              ship and associating factors. J Hypertens 2002; 20: 2415 – 2422.
15.   Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley        24.   Hashimoto J, Watabe D, Kimura A, Takahashi H, Ohkubo T, Totsune
      P, et al. Aortic stiffness is an independent predictor of primary coro-         K, et al. Determinants of the second derivative of the finger photo-
      nary events in hypertensive patients: A longitudinal study. Hyperten-           plethysmogram and brachial-ankle pulse-wave velocity: The
      sion 2002; 39: 10 – 15.                                                         Ohasama study. Am J Hypertens 2005; 18: 477 – 485.
16.   Shokawa T, Imazu M, Yamamoto H, Toyofuku M, Tasaki N, Okimoto             25.   Imanaga I, Hara H, Koyanagi S, Tanaka K. Correlation between
      T, et al. Pulse wave velocity predicts cardiovascular mortality: Find-          wave components of the second derivative of plethysmogram and
      ings from the Hawaii-Los Angeles-Hiroshima study. Circ J 2005;                  arterial distensibility. Jpn Heart J 1998; 39: 775 – 784.
      69: 259 – 264.                                                            26.   Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H,
17.   Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse                      Kannel WB. Prediction of coronary heart disease using risk factor
      pressure useful in predicting risk for coronary heart disease? The              categories. Circulation 1998; 97: 1837 – 1847.
      Framingham heart study. Circulation 1999; 100: 354 – 360.                 27.   Jespersen LT, Pedersen OL. The quantitative aspect of photoplethys-
18.   Domanski M, Norman J, Wolz M, Mitchell G, Pfeffer M. Cardiovas-                 mography revised. Heart Vessels 1986; 2: 186 – 190.
      cular risk assessment using pulse pressure in the first national health    28.   Iketani Y, Iketani T, Takazawa K, Murata M. Second derivative of
      and nutrition examination survey (NHANES I). Hypertension 2001;                 photoplethysmogram in children and young people. Jpn Circ J 2000;
      38: 793 – 797.                                                                  64: 110 – 116.
19.   Takazawa K, Tanaka N, Fujita M, Matsuoka O, Saiki T, Aikawa M,            29.   Bland JM, Altman DG. Statistical methods for assessing agreement
      et al. Assessment of vasoactive agents and vascular aging by the                between two methods of clinical measurement. Lancet 1986; 1: 307 –
      second derivative of photoplethysmogram waveform. Hypertension                  310.
      1998; 32: 365 – 370.                                                      30.   Kelly RP, Millasseau SC, Ritter JM, Chowienczyk PJ. Vasoactive
20.   Takada H, Washino K, Harrell JS, Iwata H. Acceleration plethysmo-               drugs influence aortic augmentation index independently of pulse-
      graphy to evaluate aging effect in cardiovascular system: Using new             wave velocity in healthy men. Hypertension 2001; 37: 1429 – 1433.
      criteria of four wave patterns. Med Prog Technol 1996; 21: 205 –          31.   Ferrari AU, Radaelli A, Centola M. Invited review: Aging and the
      210.                                                                            cardiovascular system. J Appl Physiol 2003; 95: 2591 – 2597.
21.   Takazawa K, Fujita M, Yabe K, Saiki T, Kobayashi T, Maeda K, et           32.   Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann
      al. Clinical usefulness of the second derivative of a plethysmogram             SP, et al. AHA Guidelines for Primary Prevention of Cardiovascular
      (acceleration plethysmogram). J Cardiol 1993; 23: 207 – 217.                    Disease and Stroke: 2002 Update: Consensus Panel Guide to Com-
22.   Bortolotto LA, Blacher J, Kondo T, Takazawa K, Safar ME. Assess-                prehensive Risk Reduction for Adult Patients Without Coronary or
      ment of vascular aging and atherosclerosis in hypertensive subjects:            Other Atherosclerotic Vascular Diseases. Circulation 2002; 106:
      Second derivative of photoplethysmogram versus pulse wave veloci-               388 – 391.
      ty. Am J Hypertens 2000; 13: 165 – 171.                                   33.   Suka M, Sugimori H, Yoshida K. Application of the updated Fram-
23.   Hashimoto J, Chonan K, Aoki Y, Nishimura T, Ohkubo T, Hozawa                    ingham risk score to Japanese men. Hypertens Res 2001; 24: 685 –
      A, et al. Pulse wave velocity and the second derivative of the finger            689.




                                                                                                              Circulation Journal Vol.70, March 2006

More Related Content

What's hot

Improved diagnosis and prognosis using Decisions Informed by Combining Entiti...
Improved diagnosis and prognosis using Decisions Informed by Combining Entiti...Improved diagnosis and prognosis using Decisions Informed by Combining Entiti...
Improved diagnosis and prognosis using Decisions Informed by Combining Entiti...
Cardiovascular Diagnosis and Therapy (CDT)
 
Closer look at stroke in maine for maine stroke alliance 2019 final
Closer look at stroke in maine for maine stroke alliance 2019  finalCloser look at stroke in maine for maine stroke alliance 2019  final
Closer look at stroke in maine for maine stroke alliance 2019 final
Gillian Gordon Perue
 
Future of site stable to unstable
Future of site stable to unstableFuture of site stable to unstable
Future of site stable to unstable
optimacardio
 
EVAPORATE: Icosapent Ethyl on Progression of Coronary Atherosclerosis in Pati...
EVAPORATE: Icosapent Ethyl on Progression of Coronary Atherosclerosis in Pati...EVAPORATE: Icosapent Ethyl on Progression of Coronary Atherosclerosis in Pati...
EVAPORATE: Icosapent Ethyl on Progression of Coronary Atherosclerosis in Pati...
Chi Pham
 
Heinz Nixdorf Erbel
Heinz Nixdorf ErbelHeinz Nixdorf Erbel
Heinz Nixdorf Erbel
hospital
 
12471_2015_Article_733
12471_2015_Article_73312471_2015_Article_733
12471_2015_Article_733
Brian Vendel
 
Nstemi invasive treatment rationale and timing
Nstemi invasive treatment rationale and timingNstemi invasive treatment rationale and timing
Nstemi invasive treatment rationale and timing
optimacardio
 
Base Primary Prevention Decision Model
Base Primary Prevention Decision ModelBase Primary Prevention Decision Model
Base Primary Prevention Decision Model
CTSI at UCSF
 
Coronary CTA: The test of choice for obstructive CAD.
Coronary CTA: The test of choice for obstructive CAD.Coronary CTA: The test of choice for obstructive CAD.
Coronary CTA: The test of choice for obstructive CAD.
cardiositeindia
 
Wivon
WivonWivon
Novel Method for Automated Analysis of Retinal Images: Results in Subjects wi...
Novel Method for Automated Analysis of Retinal Images: Results in Subjects wi...Novel Method for Automated Analysis of Retinal Images: Results in Subjects wi...
Novel Method for Automated Analysis of Retinal Images: Results in Subjects wi...
Mutiple Sclerosis
 
Evaporate trial
Evaporate trialEvaporate trial
Evaporate trial
Priyanka Thakur
 
Land mark trials 2015
Land mark trials 2015Land mark trials 2015
Land mark trials 2015
madhusiva03
 
Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardi...
Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardi...Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardi...
Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardi...
inventionjournals
 
Excerise Tolerance and Post-Operative Outcomes in Patients with Pulmonary Hyp...
Excerise Tolerance and Post-Operative Outcomes in Patients with Pulmonary Hyp...Excerise Tolerance and Post-Operative Outcomes in Patients with Pulmonary Hyp...
Excerise Tolerance and Post-Operative Outcomes in Patients with Pulmonary Hyp...
Aalap Shah
 
Bhargav2017 article regression_ofophthalmopathicexo
Bhargav2017 article regression_ofophthalmopathicexoBhargav2017 article regression_ofophthalmopathicexo
Bhargav2017 article regression_ofophthalmopathicexo
PIMS2107
 
Knowledge, attitude and practice about hypertension among adult
Knowledge, attitude and practice about hypertension among adultKnowledge, attitude and practice about hypertension among adult
Knowledge, attitude and practice about hypertension among adult
Md.Nahian Rahman
 
Jose miguel vegas valle sec sept2015
Jose miguel vegas valle sec sept2015Jose miguel vegas valle sec sept2015
Drug-Eluting Stents for Multivessel PCI
Drug-Eluting Stents for Multivessel PCIDrug-Eluting Stents for Multivessel PCI
Drug-Eluting Stents for Multivessel PCI
Sociedad Latinoamericana de Cardiología Intervencionista
 
Hanan fathy
Hanan fathyHanan fathy
Hanan fathy
Prof. Rehab Yousef
 

What's hot (20)

Improved diagnosis and prognosis using Decisions Informed by Combining Entiti...
Improved diagnosis and prognosis using Decisions Informed by Combining Entiti...Improved diagnosis and prognosis using Decisions Informed by Combining Entiti...
Improved diagnosis and prognosis using Decisions Informed by Combining Entiti...
 
Closer look at stroke in maine for maine stroke alliance 2019 final
Closer look at stroke in maine for maine stroke alliance 2019  finalCloser look at stroke in maine for maine stroke alliance 2019  final
Closer look at stroke in maine for maine stroke alliance 2019 final
 
Future of site stable to unstable
Future of site stable to unstableFuture of site stable to unstable
Future of site stable to unstable
 
EVAPORATE: Icosapent Ethyl on Progression of Coronary Atherosclerosis in Pati...
EVAPORATE: Icosapent Ethyl on Progression of Coronary Atherosclerosis in Pati...EVAPORATE: Icosapent Ethyl on Progression of Coronary Atherosclerosis in Pati...
EVAPORATE: Icosapent Ethyl on Progression of Coronary Atherosclerosis in Pati...
 
Heinz Nixdorf Erbel
Heinz Nixdorf ErbelHeinz Nixdorf Erbel
Heinz Nixdorf Erbel
 
12471_2015_Article_733
12471_2015_Article_73312471_2015_Article_733
12471_2015_Article_733
 
Nstemi invasive treatment rationale and timing
Nstemi invasive treatment rationale and timingNstemi invasive treatment rationale and timing
Nstemi invasive treatment rationale and timing
 
Base Primary Prevention Decision Model
Base Primary Prevention Decision ModelBase Primary Prevention Decision Model
Base Primary Prevention Decision Model
 
Coronary CTA: The test of choice for obstructive CAD.
Coronary CTA: The test of choice for obstructive CAD.Coronary CTA: The test of choice for obstructive CAD.
Coronary CTA: The test of choice for obstructive CAD.
 
Wivon
WivonWivon
Wivon
 
Novel Method for Automated Analysis of Retinal Images: Results in Subjects wi...
Novel Method for Automated Analysis of Retinal Images: Results in Subjects wi...Novel Method for Automated Analysis of Retinal Images: Results in Subjects wi...
Novel Method for Automated Analysis of Retinal Images: Results in Subjects wi...
 
Evaporate trial
Evaporate trialEvaporate trial
Evaporate trial
 
Land mark trials 2015
Land mark trials 2015Land mark trials 2015
Land mark trials 2015
 
Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardi...
Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardi...Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardi...
Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardi...
 
Excerise Tolerance and Post-Operative Outcomes in Patients with Pulmonary Hyp...
Excerise Tolerance and Post-Operative Outcomes in Patients with Pulmonary Hyp...Excerise Tolerance and Post-Operative Outcomes in Patients with Pulmonary Hyp...
Excerise Tolerance and Post-Operative Outcomes in Patients with Pulmonary Hyp...
 
Bhargav2017 article regression_ofophthalmopathicexo
Bhargav2017 article regression_ofophthalmopathicexoBhargav2017 article regression_ofophthalmopathicexo
Bhargav2017 article regression_ofophthalmopathicexo
 
Knowledge, attitude and practice about hypertension among adult
Knowledge, attitude and practice about hypertension among adultKnowledge, attitude and practice about hypertension among adult
Knowledge, attitude and practice about hypertension among adult
 
Jose miguel vegas valle sec sept2015
Jose miguel vegas valle sec sept2015Jose miguel vegas valle sec sept2015
Jose miguel vegas valle sec sept2015
 
Drug-Eluting Stents for Multivessel PCI
Drug-Eluting Stents for Multivessel PCIDrug-Eluting Stents for Multivessel PCI
Drug-Eluting Stents for Multivessel PCI
 
Hanan fathy
Hanan fathyHanan fathy
Hanan fathy
 

Viewers also liked

Pulseox[1]
Pulseox[1]Pulseox[1]
Pulseox[1]
ES-Teck India
 
Serotonin ssri effects
Serotonin ssri effectsSerotonin ssri effects
Serotonin ssri effects
ES-Teck India
 
Stptg 4
Stptg 4Stptg 4
Stptg 4
ES-Teck India
 
EIS technology : bioimpedance application in selective serotonin reuptake
EIS technology : bioimpedance application in selective serotonin reuptakeEIS technology : bioimpedance application in selective serotonin reuptake
EIS technology : bioimpedance application in selective serotonin reuptake
ES-Teck India
 
EIS Technology: New marker using bioimpedance technology in screening for ADHD
EIS Technology: New marker using bioimpedance technology in screening for ADHDEIS Technology: New marker using bioimpedance technology in screening for ADHD
EIS Technology: New marker using bioimpedance technology in screening for ADHD
ES-Teck India
 
Summary of clinical investigations es teck complex system
Summary of clinical investigations es teck complex systemSummary of clinical investigations es teck complex system
Summary of clinical investigations es teck complex system
ES-Teck India
 
EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...
EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...
EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...
ES-Teck India
 
ESO system, ES-BC system and EIS-GS system - Miami University study
ESO system, ES-BC system and EIS-GS system - Miami University study ESO system, ES-BC system and EIS-GS system - Miami University study
ESO system, ES-BC system and EIS-GS system - Miami University study
ES-Teck India
 
Es teck india
Es teck indiaEs teck india
Es teck india
ES-Teck India
 

Viewers also liked (9)

Pulseox[1]
Pulseox[1]Pulseox[1]
Pulseox[1]
 
Serotonin ssri effects
Serotonin ssri effectsSerotonin ssri effects
Serotonin ssri effects
 
Stptg 4
Stptg 4Stptg 4
Stptg 4
 
EIS technology : bioimpedance application in selective serotonin reuptake
EIS technology : bioimpedance application in selective serotonin reuptakeEIS technology : bioimpedance application in selective serotonin reuptake
EIS technology : bioimpedance application in selective serotonin reuptake
 
EIS Technology: New marker using bioimpedance technology in screening for ADHD
EIS Technology: New marker using bioimpedance technology in screening for ADHDEIS Technology: New marker using bioimpedance technology in screening for ADHD
EIS Technology: New marker using bioimpedance technology in screening for ADHD
 
Summary of clinical investigations es teck complex system
Summary of clinical investigations es teck complex systemSummary of clinical investigations es teck complex system
Summary of clinical investigations es teck complex system
 
EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...
EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...
EIS Technology: bioimpedance chronoamperometry in adjunct to screen the prost...
 
ESO system, ES-BC system and EIS-GS system - Miami University study
ESO system, ES-BC system and EIS-GS system - Miami University study ESO system, ES-BC system and EIS-GS system - Miami University study
ESO system, ES-BC system and EIS-GS system - Miami University study
 
Es teck india
Es teck indiaEs teck india
Es teck india
 

Similar to Stptg 2

AHA NPAM EPI 2007 Abstract
AHA NPAM EPI 2007 AbstractAHA NPAM EPI 2007 Abstract
AHA NPAM EPI 2007 Abstract
Robert Lowe
 
HIGH SENSITIVE C-REACTIVE PROTEIN (hs-CRP) AND ITS CORRELATION WITH ANGIOGRAP...
HIGH SENSITIVE C-REACTIVE PROTEIN (hs-CRP) AND ITS CORRELATION WITH ANGIOGRAP...HIGH SENSITIVE C-REACTIVE PROTEIN (hs-CRP) AND ITS CORRELATION WITH ANGIOGRAP...
HIGH SENSITIVE C-REACTIVE PROTEIN (hs-CRP) AND ITS CORRELATION WITH ANGIOGRAP...
M A Hasnat
 
J dhaka med coll. 2010 19(2) 91 97.
J dhaka med coll. 2010  19(2) 91 97.J dhaka med coll. 2010  19(2) 91 97.
J dhaka med coll. 2010 19(2) 91 97.
DrMAHasnat
 
Sdptg1
Sdptg1Sdptg1
Kwon et.al
Kwon et.alKwon et.al
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
semualkaira
 
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
semualkaira
 
Benefits of RCA CTO-PCI Based on Clinical Data.pptx
Benefits of RCA CTO-PCI Based on Clinical Data.pptxBenefits of RCA CTO-PCI Based on Clinical Data.pptx
Benefits of RCA CTO-PCI Based on Clinical Data.pptx
Yamaguchi Yukihiro
 
The Use of Artificial Neural Network and Logistic Regression to Predict the I...
The Use of Artificial Neural Network and Logistic Regression to Predict the I...The Use of Artificial Neural Network and Logistic Regression to Predict the I...
The Use of Artificial Neural Network and Logistic Regression to Predict the I...
Crimsonpublisherscojnh
 
Challenging Factors Influencing Biodiversity_ Crimson Publishers
Challenging Factors Influencing Biodiversity_ Crimson PublishersChallenging Factors Influencing Biodiversity_ Crimson Publishers
Challenging Factors Influencing Biodiversity_ Crimson Publishers
CrimsonpublishersEAES
 
No correlation and low agreement of imaging and inflammatory atherosclerosis’...
No correlation and low agreement of imaging and inflammatory atherosclerosis’...No correlation and low agreement of imaging and inflammatory atherosclerosis’...
No correlation and low agreement of imaging and inflammatory atherosclerosis’...
SHAPE Society
 
Year-by-year trend analysis in modifiable risk factors reduction
Year-by-year trend analysis in modifiable risk factors reductionYear-by-year trend analysis in modifiable risk factors reduction
Year-by-year trend analysis in modifiable risk factors reduction
Abd Alrahman Kfmc
 
Poster Experimental Biology 2014
Poster Experimental Biology 2014Poster Experimental Biology 2014
Poster Experimental Biology 2014
Vicente RIBAS-RIPOLL
 
Brachial artery and its relationship with carotid artery
Brachial artery and its relationship with carotid arteryBrachial artery and its relationship with carotid artery
Brachial artery and its relationship with carotid artery
ALEXANDRU ANDRITOIU
 
Cardiac risk evaluation: searching for the vulnerable patient
Cardiac risk evaluation: searching for the vulnerable patient Cardiac risk evaluation: searching for the vulnerable patient
Cardiac risk evaluation: searching for the vulnerable patient
FELIX NUNURA
 
Executive summary module 1
Executive summary module 1Executive summary module 1
Executive summary module 1
RioAlexsandro1
 
Executive summary module 1
Executive summary module 1Executive summary module 1
Executive summary module 1
RioAlexsandro1
 
A STUDY ON PREVALENCE OF MICRO AND MACRO VASCULAR COMPLICATIONS IN TYPE 2 DI...
A STUDY ON PREVALENCE OF MICRO AND MACRO VASCULAR  COMPLICATIONS IN TYPE 2 DI...A STUDY ON PREVALENCE OF MICRO AND MACRO VASCULAR  COMPLICATIONS IN TYPE 2 DI...
A STUDY ON PREVALENCE OF MICRO AND MACRO VASCULAR COMPLICATIONS IN TYPE 2 DI...
IJSIT Editor
 
Systematic literature review services | Cardiovascular research | Bariatric s...
Systematic literature review services | Cardiovascular research | Bariatric s...Systematic literature review services | Cardiovascular research | Bariatric s...
Systematic literature review services | Cardiovascular research | Bariatric s...
Pubrica
 
Stroke related pneumonia _ APSR 2019 - Phuc Duc Dang
Stroke related pneumonia  _ APSR 2019 - Phuc Duc DangStroke related pneumonia  _ APSR 2019 - Phuc Duc Dang
Stroke related pneumonia _ APSR 2019 - Phuc Duc Dang
dangphucduc
 

Similar to Stptg 2 (20)

AHA NPAM EPI 2007 Abstract
AHA NPAM EPI 2007 AbstractAHA NPAM EPI 2007 Abstract
AHA NPAM EPI 2007 Abstract
 
HIGH SENSITIVE C-REACTIVE PROTEIN (hs-CRP) AND ITS CORRELATION WITH ANGIOGRAP...
HIGH SENSITIVE C-REACTIVE PROTEIN (hs-CRP) AND ITS CORRELATION WITH ANGIOGRAP...HIGH SENSITIVE C-REACTIVE PROTEIN (hs-CRP) AND ITS CORRELATION WITH ANGIOGRAP...
HIGH SENSITIVE C-REACTIVE PROTEIN (hs-CRP) AND ITS CORRELATION WITH ANGIOGRAP...
 
J dhaka med coll. 2010 19(2) 91 97.
J dhaka med coll. 2010  19(2) 91 97.J dhaka med coll. 2010  19(2) 91 97.
J dhaka med coll. 2010 19(2) 91 97.
 
Sdptg1
Sdptg1Sdptg1
Sdptg1
 
Kwon et.al
Kwon et.alKwon et.al
Kwon et.al
 
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
 
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
The Impact of Lymph Node Dissection on Survival in Intermediate- and High-Ris...
 
Benefits of RCA CTO-PCI Based on Clinical Data.pptx
Benefits of RCA CTO-PCI Based on Clinical Data.pptxBenefits of RCA CTO-PCI Based on Clinical Data.pptx
Benefits of RCA CTO-PCI Based on Clinical Data.pptx
 
The Use of Artificial Neural Network and Logistic Regression to Predict the I...
The Use of Artificial Neural Network and Logistic Regression to Predict the I...The Use of Artificial Neural Network and Logistic Regression to Predict the I...
The Use of Artificial Neural Network and Logistic Regression to Predict the I...
 
Challenging Factors Influencing Biodiversity_ Crimson Publishers
Challenging Factors Influencing Biodiversity_ Crimson PublishersChallenging Factors Influencing Biodiversity_ Crimson Publishers
Challenging Factors Influencing Biodiversity_ Crimson Publishers
 
No correlation and low agreement of imaging and inflammatory atherosclerosis’...
No correlation and low agreement of imaging and inflammatory atherosclerosis’...No correlation and low agreement of imaging and inflammatory atherosclerosis’...
No correlation and low agreement of imaging and inflammatory atherosclerosis’...
 
Year-by-year trend analysis in modifiable risk factors reduction
Year-by-year trend analysis in modifiable risk factors reductionYear-by-year trend analysis in modifiable risk factors reduction
Year-by-year trend analysis in modifiable risk factors reduction
 
Poster Experimental Biology 2014
Poster Experimental Biology 2014Poster Experimental Biology 2014
Poster Experimental Biology 2014
 
Brachial artery and its relationship with carotid artery
Brachial artery and its relationship with carotid arteryBrachial artery and its relationship with carotid artery
Brachial artery and its relationship with carotid artery
 
Cardiac risk evaluation: searching for the vulnerable patient
Cardiac risk evaluation: searching for the vulnerable patient Cardiac risk evaluation: searching for the vulnerable patient
Cardiac risk evaluation: searching for the vulnerable patient
 
Executive summary module 1
Executive summary module 1Executive summary module 1
Executive summary module 1
 
Executive summary module 1
Executive summary module 1Executive summary module 1
Executive summary module 1
 
A STUDY ON PREVALENCE OF MICRO AND MACRO VASCULAR COMPLICATIONS IN TYPE 2 DI...
A STUDY ON PREVALENCE OF MICRO AND MACRO VASCULAR  COMPLICATIONS IN TYPE 2 DI...A STUDY ON PREVALENCE OF MICRO AND MACRO VASCULAR  COMPLICATIONS IN TYPE 2 DI...
A STUDY ON PREVALENCE OF MICRO AND MACRO VASCULAR COMPLICATIONS IN TYPE 2 DI...
 
Systematic literature review services | Cardiovascular research | Bariatric s...
Systematic literature review services | Cardiovascular research | Bariatric s...Systematic literature review services | Cardiovascular research | Bariatric s...
Systematic literature review services | Cardiovascular research | Bariatric s...
 
Stroke related pneumonia _ APSR 2019 - Phuc Duc Dang
Stroke related pneumonia  _ APSR 2019 - Phuc Duc DangStroke related pneumonia  _ APSR 2019 - Phuc Duc Dang
Stroke related pneumonia _ APSR 2019 - Phuc Duc Dang
 

More from ES-Teck India

Sdptg 3
Sdptg 3Sdptg 3
Sdptg 3
ES-Teck India
 
Pulse wave reflection
Pulse wave reflectionPulse wave reflection
Pulse wave reflection
ES-Teck India
 
Pulse wave indice
Pulse wave indicePulse wave indice
Pulse wave indice
ES-Teck India
 
Pulse wave analysis
Pulse wave analysisPulse wave analysis
Pulse wave analysis
ES-Teck India
 
Ptg and cardiac output.jsp
Ptg and cardiac output.jspPtg and cardiac output.jsp
Ptg and cardiac output.jsp
ES-Teck India
 
Guidelines heart rate_variability_ft_1996[1]
Guidelines heart rate_variability_ft_1996[1]Guidelines heart rate_variability_ft_1996[1]
Guidelines heart rate_variability_ft_1996[1]
ES-Teck India
 
Arterioscler thromb vasc_biol_22_147
Arterioscler thromb vasc_biol_22_147Arterioscler thromb vasc_biol_22_147
Arterioscler thromb vasc_biol_22_147
ES-Teck India
 
Angitensin and ptg
Angitensin and ptgAngitensin and ptg
Angitensin and ptg
ES-Teck India
 
About pulseoximetry
About pulseoximetryAbout pulseoximetry
About pulseoximetry
ES-Teck India
 
Serotonin and blood flow
Serotonin and blood flowSerotonin and blood flow
Serotonin and blood flow
ES-Teck India
 
Oxidative stress
Oxidative stressOxidative stress
Oxidative stress
ES-Teck India
 
Fat mass and leptin
Fat mass and leptinFat mass and leptin
Fat mass and leptin
ES-Teck India
 
Dopamine
DopamineDopamine
Dopamine
ES-Teck India
 
Dopamine and ischemia
Dopamine and ischemiaDopamine and ischemia
Dopamine and ischemiaES-Teck India
 
Dopamine and atp+ hypoxia
Dopamine and atp+ hypoxiaDopamine and atp+ hypoxia
Dopamine and atp+ hypoxia
ES-Teck India
 
Correlation between organ dysfunctions and vertebral displacements
Correlation between organ dysfunctions and vertebral displacementsCorrelation between organ dysfunctions and vertebral displacements
Correlation between organ dysfunctions and vertebral displacements
ES-Teck India
 
Impedance dispersion
Impedance dispersionImpedance dispersion
Impedance dispersion
ES-Teck India
 
Bioimpedance principles
Bioimpedance principlesBioimpedance principles
Bioimpedance principles
ES-Teck India
 
Bioimpedance overview
Bioimpedance overview Bioimpedance overview
Bioimpedance overview
ES-Teck India
 
Bioimpedance density distribution
Bioimpedance density distribution Bioimpedance density distribution
Bioimpedance density distribution
ES-Teck India
 

More from ES-Teck India (20)

Sdptg 3
Sdptg 3Sdptg 3
Sdptg 3
 
Pulse wave reflection
Pulse wave reflectionPulse wave reflection
Pulse wave reflection
 
Pulse wave indice
Pulse wave indicePulse wave indice
Pulse wave indice
 
Pulse wave analysis
Pulse wave analysisPulse wave analysis
Pulse wave analysis
 
Ptg and cardiac output.jsp
Ptg and cardiac output.jspPtg and cardiac output.jsp
Ptg and cardiac output.jsp
 
Guidelines heart rate_variability_ft_1996[1]
Guidelines heart rate_variability_ft_1996[1]Guidelines heart rate_variability_ft_1996[1]
Guidelines heart rate_variability_ft_1996[1]
 
Arterioscler thromb vasc_biol_22_147
Arterioscler thromb vasc_biol_22_147Arterioscler thromb vasc_biol_22_147
Arterioscler thromb vasc_biol_22_147
 
Angitensin and ptg
Angitensin and ptgAngitensin and ptg
Angitensin and ptg
 
About pulseoximetry
About pulseoximetryAbout pulseoximetry
About pulseoximetry
 
Serotonin and blood flow
Serotonin and blood flowSerotonin and blood flow
Serotonin and blood flow
 
Oxidative stress
Oxidative stressOxidative stress
Oxidative stress
 
Fat mass and leptin
Fat mass and leptinFat mass and leptin
Fat mass and leptin
 
Dopamine
DopamineDopamine
Dopamine
 
Dopamine and ischemia
Dopamine and ischemiaDopamine and ischemia
Dopamine and ischemia
 
Dopamine and atp+ hypoxia
Dopamine and atp+ hypoxiaDopamine and atp+ hypoxia
Dopamine and atp+ hypoxia
 
Correlation between organ dysfunctions and vertebral displacements
Correlation between organ dysfunctions and vertebral displacementsCorrelation between organ dysfunctions and vertebral displacements
Correlation between organ dysfunctions and vertebral displacements
 
Impedance dispersion
Impedance dispersionImpedance dispersion
Impedance dispersion
 
Bioimpedance principles
Bioimpedance principlesBioimpedance principles
Bioimpedance principles
 
Bioimpedance overview
Bioimpedance overview Bioimpedance overview
Bioimpedance overview
 
Bioimpedance density distribution
Bioimpedance density distribution Bioimpedance density distribution
Bioimpedance density distribution
 

Recently uploaded

CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
Jim Jacob Roy
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
Government Dental College & Hospital Srinagar
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
NX Healthcare
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Traumasoft LLC
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
anaghabharat01
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 

Recently uploaded (20)

CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 

Stptg 2

  • 1. Circ J 2006; 70: 304 – 310 Utility of Second Derivative of the Finger Photoplethysmogram for the Estimation of the Risk of Coronary Heart Disease in the General Population Toshiaki Otsuka, MD; Tomoyuki Kawada, MD; Masao Katsumata, PhD; Chikao Ibuki, MD* Background Increased arterial stiffness has been shown to be associated with coronary heart disease (CHD). However, it remains unclear as to whether the second derivative of the finger photoplethysmogram (SDPTG), a non-invasive method for the assessment of arterial stiffness, is useful for the estimation of risk of CHD in the general population. Methods and Results The SDPTG in 211 subjects (age: 63±15 years, range: 21–91 years, 93 males) was recorded without apparent atherosclerotic disorders from a community. The relationship between the SDPTG indices (b/a and d/a) and coronary risk factors (n=211) or the Framingham risk score (n=158, age: 60±12 years, range: 30–74 years, 63 males) were analyzed. The SDPTG indices significantly correlated with the Framingham risk score in both genders (b/a; rmale =0.43, rfemale =0.54 and d/a; rmale =–0.38, rfemale =–0.58), as well as several coronary risk factors. In the receiver operating characteristics curve analyses, the b/a discriminated high-risk sub- jects for CHD, who were in the highest quintile of the Framingham risk score in each gender, with a sensitivity and specificity of 0.85 and 0.58 in males and 0.83 and 0.72 in females, respectively. Conclusions These results suggest that the SDPTG is useful for the estimation of risk of CHD in the general population. (Circ J 2006; 70: 304 – 310) Key Words: Arterial stiffness; Cardiovascular preventive medicine; Coronary heart disease; Framingham risk score; Second derivative of the finger photoplethysmogram C oronary heart disease (CHD) is still one of the index (AIx).19,21 In addition, the SDPTG indices were inde- 1 major causes of deaths in Japan. Moreover, CHD pendently influenced by several risk factors for atheroscle- mortality is expected to increase in the near future rosis in patients with hypertension23 and in the general because the lifestyles of the Japanese, such as their dietary 24 population. However, it is still unclear as to whether the 2 habits, have become westernized. Indeed, it has been SDPTG indices are related to the coronary risk factors, or reported that young Japanese patients with CHD who have moreover, the risk for the future development of CHD in multiple coronary risk factors, including hypertension, apparently healthy individuals. hyperlipidemia, and obesity, all of which might be associ- Thus, we conducted a cross-sectional study in a Japanese 3 ated with their lifestyles, have been increasing. Therefore, community to assess the relationship between the SDPTG it is important in the field of cardiovascular preventive indices and coronary risk factors in subjects with no appar- medicine to identify those at risk of CHD in general popu- ent atherosclerotic disorders. Furthermore, we calculated lations. 26 the Framingham risk score, which has been used to esti- Increased arterial stiffness has been shown to be associ- mate an individual’s risk of CHD, and determined the 4–11 ated not only with several coronary risk factors, but also optimal cut-off points of the SDPTG indices to discrimi- with the future development of CHD. 12–18 Recently, the nate individuals at risk of CHD. second derivative of the finger photoplethysmogram (SDPTG) has been developed as one of the non-invasive and convenient methods for pulse-wave analysis. 19–21 The Methods SDPTG is obtained from double differentiation of the Study Population finger photoplethysmogram (PTG) and is thought to pro- In the present study, 211 subjects (age: 63±15 years, vide structural and functional properties of both central and range: 21–91 years, 93 males) who underwent both SDPTG 19 peripheral arteries. Indeed, an index calculated from the recording and blood sampling after an overnight fast were SDPTG showed a significant association with age, 19,20,22–24 recruited from the annual health examination in a commu- 25 carotid arterial distensibility, and the aortic augmentation nity, Yamanashi, Japan, in 2004 and 2005. Subjects with a history or presence of atherosclerotic disorders, such as (Received July 1, 2005; revised manuscript received December 12, CHD, stroke, and peripheral obstructive arterial disease, 2005; accepted December 19, 2005) were excluded from the study. We also excluded subjects Environmental Medicine, Graduate School of Medicine, *Department with renal dysfunction (serum creatinine ≥1.3 mg/dl) or of Internal Medicine and Cardiology, Tama-Nagayama Hospital, Nippon Medical School, Tokyo, Japan patients who had taken medications for hypertension, Mailing address: Toshiaki Otsuka, MD, Environmental Medicine, hyperlipidemia, or diabetes mellitus. Subjects with abnor- Graduate School of Medicine, Nippon Medical School, 1-1-5 Sendagi, mal Q-waves on the 12-lead electrocardiogram at rest were Bunkyo-ku, Tokyo 113-8603, Japan. E-mail: otsuka@nms.ac.jp also excluded. This study protocol was approved by the Circulation Journal Vol.70, March 2006
  • 2. SDPTG and Risk of CHD 305 Table 1 Clinical Characteristics and SDPTG Indices of Study Subjects (n=211) Parameters Age (years) 63±15 <40 20 (9.5%) 40–49 18 (8.5%) 50–59 34 (16.1%) 60–69 56 (26.5%) 70–79 65 (30.8%) ≥80 18 (8.6%) Male gender 93 (44.1%) BMI (kg/m2) 22.6±3.1 SBP (mmHg) 130±18 DBP (mmHg) 76±12 PP (mmHg) 54±12 TC (mg/dl) 199±37 TG (mg/dl) 96±72 HDLC (mg/dl) 59±16 TC/HDLC ratio 3.6±1.1 FPG (mg/dl) 93±11 Hypertension 59 (28.0%) Hyperlipidemia 65 (30.8%) Fig 1. A schema of the finger photoplethysmogram (PTG, Top) and Obesity 39 (18.5%) the second derivative of the finger photoplethysmogram (SDPTG, Diabetes mellitus 0 (0%) Bottom). The SDPTG consists of 5 waves and each wave is consecu- Smoking 23 (16.3%) tively named ‘a’, ‘b’, ‘c’, ‘d’, and ‘e’ wave, respectively. The ‘a’ and SDPTG indices ‘b’ waves are included in the early systolic phase and the ‘c’ and ‘d’ b/a –0.46±0.14 waves in the late systolic phase of the PTG. d/a –0.36±0.13 Presented values are the mean ± SD or number of subjects (percent of total). Hypertension was defined as SBP ≥140 mmHg and/or DBP ≥90 mmHg. Hyperlipidemia was defined as TC ≥220 mg/dl and/or TG ≥150 mmHg. ethics committee of Nippon Medical School. Written Obesity was defined as BMI ≥25 kg/m2. Diabetes mellitus was defined as informed consent was obtained from all participants. FPG ≥140 mg/dl. Smoking was defined as regularly smoking during the previous 12 months. Measurements of the Data SDPTG, second derivative of the finger photoplethysmogram; BMI, body Blood sampling and hemodynamic measurements were mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; conducted in a temperature-controlled room maintained at PP, pulse pressure; TC, total cholesterol; TG, triglycerides; HDLC, high- density lipoprotein cholesterol; FPG, fasting plasma glucose. 24±2°C. Blood samples were collected from the antecu- bital vein in each participant after an overnight fast. Serum total cholesterol (TC), triglycerides, and plasma glucose were measured by enzymatic reference methods on an phase of the PTG, whereas the ‘c’ and ‘d’ waves are in- automated analyzer. Serum high-density lipoprotein cho- cluded in the late systolic phase. The height of each wave lesterol (HDLC) was analyzed using a direct method based from the baseline was measured and the ratios of the height on the selective solubilizing effect. Systolic blood pressure of the ‘a’ wave to that of the ‘b’ and ‘d’ waves (b/a and d/a) (SBP) and diastolic blood pressure (DBP) were measured were calculated and used as the SDPTG indices in the pres- by means of an automated oscillometric device (USM- ent study. 700GSi, Elquest Corporation, Chiba, Japan), after the subject had been resting for at least 5 min in a sitting posi- Assessment of Individual’s CHD Risk Level tion. Pulse pressure (PP) was defined as the difference In 158 subjects who were aged 30 to 74 years (mean age: between the SBP and DBP. The SDPTG was recorded in 60±12 years, 63 males), the individual’s CHD risk level the supine position using an SDP-100 instrument (Fukuda was estimated based on the Framingham CHD score sheets Denshi, Tokyo, Japan), when the subject had been resting 26 presented by Wilson et al. This scoring system was for at least 5 min in the same position. A transducer was applied only to subjects with an age ranging from 30 to 74 placed on the cuticle of the index finger of the left hand and years; therefore, 45 subjects over the age of 75 and 8 sub- the signal of the blood volume changes in the peripheral jects under the age of 30 were excluded from this assess- circulation, which indicated PTG, was sent to the SDP-100. ment. The details of the algorithm for the determination of The PTG describes the changes in the absorption of light 26 the risk score are described in the original report. In brief, by hemoglobin using a waveform according to the Lambert- 6 risk factors (age, gender, blood pressure, cholesterol 27 Beer law. The details of the methodology for the measure- value, smoking status, and presence or absence of diabetes) ment of the PTG and the SDPTG are described elsewhere. 28 were changed into the respective scores and the total score The double differentiation of the PTG was then performed was used as the individual’s CHD risk level. Diabetes was automatically in the device. The reproducibility of the defined as fasting plasma glucose (FPG) ≥140 mg/dl in the SDPTG has been previously reported with an intraobserver 26 original report, and we used the same criterion in the pres- 22 repeatability of 8%, according to Bland and Altman. 29 ent study. Since subjects who were in the highest quintile A schema of the PTG and SDPTG is shown in Fig 1. The of the Framingham risk score could be regarded as ‘rela- SDPTG consists of 4 waves in systole (‘a’, ‘b’, ‘c’, and ‘d’ tively’ high-risk for CHD in a population, we defined them waves) and 1 wave in diastole (‘e’ wave). The ‘a’ and ‘b’ as high-risk subjects in each gender in the present study. waves on the SDPTG are included in the early systolic Circulation Journal Vol.70, March 2006
  • 3. 306 OTSUKA T et al. Table 2 Relationship Between the SDPTG Indices (b/a and d/a) and the Coronary Risk Factors Pearson’s correlation Multiple linear coefficient regression analysis r p value t p value b/a Age 0.52 <0.001 0.45 7.49 <0.001 Gender (Female=0, Male=1) –0.24 <0.001 –0.25 –4.27 <0.001 BMI 0.03 0.67 – SBP 0.24 <0.001 0.15 2.49 <0.05 DBP 0.10 0.14 – PP 0.26 <0.001 N TC 0.01 0.84 – TG 0.03 0.64 – HDLC –0.09 0.18 – TC/HDLC ratio 0.11 0.10 – FPG 0.13 0.06 – Smoking (No=0, Yes=1) –0.09 0.21 – (model R2 =0.33) d/a Age –0.51 <0.001 –0.43 –6.60 <0.001 Gender (Female=0, Male=1) 0.08 0.26 – BMI –0.02 0.79 – SBP –0.26 <0.001 –0.09 –1.38 0.17 DBP –0.19 <0.01 N PP –0.21 <0.01 N TC –0.06 0.41 – TG 0.00 0.99 – HDLC –0.10 0.15 – TC/HDLC ratio –0.15 <0.05 –0.04 –0.59 0.55 FPG –0.28 <0.001 –0.11 –1.78 0.08 Smoking (No=0, Yes=1) 0.07 0.30 – (model R2 =0.28) N, not included in the model. Other abbreviations see in Table 1. Statistical Analysis as a marker for the discrimination of the high-risk subjects Continuous variables and categorical data were expressed for CHD. The point on the ROC curve closest to the upper as the mean ± SD and the number of subjects (with a per- left-hand corner was defined as the optimal cut-off point. centage), respectively. Statistical analyses were performed All statistical tests were 2-sided and a p-value less than by using Dr. SPSS II software (version 11.0.1J, SPSS Japan, 0.05 was considered to be significant. Tokyo, Japan) for Windows. The relationship between the SDPTG indices and the coronary risk factors or the Fram- ingham risk score was assessed by means of Pearson’s Results moment correlation coefficient. Thereafter, multiple linear Clinical Characteristics and SDPTG Indices of the Study regression analyses were performed with the SDPTG Subjects indices as dependent variables and the coronary risk factors The clinical characteristics and the SDPTG indices of that showed significance with Pearson’s moment correla- the study subjects are shown in Table 1. The majority of tion coefficient as independent variables (except for DBP subjects were in the age range of 70 to 79 years. The mean and PP because of a high correlation with SBP). To evalu- body mass index, SBP, DBP, serum lipid levels, and FPG ate as to whether the SDPTG indices were associated with were within normal range. The prevalence of hypertension the Framingham risk score independent of age, multiple and hyperlipidemia was approximately 30%. None of the linear regression analyses were conducted with the Fram- subjects with diabetes participated in the present study. ingham risk score as dependent variables and age and the SDPTG indices as independent variables. Differences in SDPTG Indices and Coronary Risk Factors the coronary risk factors contributing to the Framingham The relationships between the SDPTG indices and coro- risk score (age, SBP, DBP, TC, HDLC, and smoking status) nary risk factors are noted in Table 2. The b/a showed a and the SDPTG indices in each quintile were analyzed significant correlation with age, gender, SBP, and PP. The using one-way analysis of variance (ANOVA) or a chi- d/a significantly correlated with age, SBP, DBP, PP, square test. Post-hoc Dunnett’s tests were performed with TC/HDLC ratio, and FPG. In the multiple linear regression the highest quintile as the control group if the ANOVA analyses, the independent variables influencing the b/a showed significance. To assess the sensitivity, specificity, were age, gender, and SBP, whereas only age indepen- and corresponding cut-off values of the SDPTG indices to dently influenced the d/a. discriminate the high-risk subjects for CHD, analyses of the receiver operating characteristic (ROC) curves were Framingham Risk Score and SDPTG Indices performed. Significance was assumed when the lower The mean Framingham risk score was 5.8±3.4 in males bound of the 95% confidence interval (CI) of the area under and 4.8±5.4 in females. The score was distributed more the ROC curve (AUC) exceeded 0.5. When the AUC was widely in females (–14–16) than in males (–3–13). The significant, the corresponding SDPTG index was identified correlations between the Framingham risk score and the Circulation Journal Vol.70, March 2006
  • 4. SDPTG and Risk of CHD 307 Fig 2. Correlations between second deriva- tive of the finger photoplethysmogram indices and the Framingham risk score in each gender. The b/a was positively corre- lated (Top), whereas the d/a inversely correlated (Bottom) with the Framingham risk score in both genders. Table 3 Coronary Risk Factors Contributing to the Framingham Risk Score and SDPTG Indices Based on the Quintile of the Score Quintile of the Framingham risk score p value Q1 Q2 Q3 Q4 Q5 for trend Male (–3–2) (3–4) (5–6) (7–8) (9–13) Number 10 11 16 13 13 Age (years) 42±9§ 52±9§ 61±10 66±4 68±7 <0.001 SBP (mmHg) 124±12§ 128±22† 123±12§ 134±18* 152±13 <0.001 DBP (mmHg) 75±11* 78±15 73±12† 81±7 89±11 <0.01 TC (mg/dl) 198±20 184±43 186±33 196±46 208±30 0.44 HDLC (mg/dl) 62±8* 63±18* 57±15 53±22 45±7 <0.05 Smoking (Yes/No) 2/8 6/5 8/8 4/9 5/8 0.44 b/a –0.64±0.08† –0.55±0.11 –0.53±0.18 –0.45±0.11 –0.46±0.11 <0.001 d/a –0.25±0.07† –0.33±0.08 –0.36±0.12 –0.37±0.14 –0.40±0.12 <0.001 Female (–14–1) (2–4) (5–6) (7–9) (10–16) Number 17 20 21 20 17 Age (years) 43±7§ 60±7* 66±6 66±7 67±7 <0.001 SBP (mmHg) 115±11§ 113±10§ 121±10§ 133±14 140±17 <0.001 DBP (mmHg) 73±9 68±9† 69±6† 75±11 79±11 <0.01 TC (mg/dl) 200±40 213±31 209±26 211±33 204±45 0.79 HDLC (mg/dl) 70±14§ 74±13§ 66±17§ 58±11† 43±9 <0.001 Smoking (Yes/No) 1/16 0/20 0/21 2/18 2/15 0.33 b/a –0.54±0.11§ –0.47±0.14* –0.39±0.09 –0.40±0.12 –0.36±0.11 <0.001 d/a –0.26±0.07§ –0.33±0.11† –0.40±0.09 –0.44±0.09 –0.44±0.11 <0.001 Presented values are the mean ± SD or number of subjects. The range of the Framingham risk score in each quintile is shown in the parentheses. §p<0.001, †p<0.01, and *p<0.05 vs the corresponding values in Q5. See Table 1 for abbreviations. SDPTG indices in each gender are shown in Fig 2. In both sion analysis, such associations were still observed inde- genders, the b/a positively correlated with the Framingham pendently of age in females (b/a; =0.32, p<0.01, d/a; = risk score (rmale =0.43 and rfemale =0.54, both p<0.001) and –0.27, p<0.001), but not in males (b/a; =0.08, d/a; = the d/a showed a negative correlation (rmale =–0.38, p<0.01 –0.02). and rfemale =–0.58, p<0.001). In the multiple linear regres- Circulation Journal Vol.70, March 2006
  • 5. 308 OTSUKA T et al. Table 4 Ability of the SDPTG Indices to Discriminate High-Risk Subjects for CHD Cut-off value Sensitivity Specificity Accuracy Male b/a –0.53 0.85 0.58 0.64 Female b/a –0.40 0.83 0.72 0.74 d/a –0.39 0.59 0.60 0.60 CHD, coronary heart disease. Other abbreviation see in Table 1. Those of the b/a and d/a in females were 0.73 (95% CI: 0.60–0.86) and 0.68 (95% CI: 0.56–0.80), respectively. In regard to the d/a in males, the AUC (0.65, 95% CI: 0.49– 0.81) did not show significance; therefore, its discrimina- tory ability and corresponding cut-off point were not analyzed. The sensitivity, specificity, and the accuracy for the discrimination of the high-risk subjects for CHD and the corresponding cut-off values are noted in Table 4. The b/a showed discriminatory performance with a sensitivity and specificity of more than 0.8 and 0.7 in females, and more than 0.8 and approximately 0.6 in males, respective- ly. However, both the sensitivity and specificity of the d/a in females were approximately 0.6. The accuracy of these indices ranged from 0.60 to 0.74. Discussion The present study showed that the SDPTG indices inde- pendently associated with several coronary risk factors and significantly correlated with the Framingham risk score. Moreover, we found that the b/a, one of the SDPTG indices, might contribute to the discrimination of the high-risk sub- jects for CHD with an acceptable sensitivity and specificity Fig 3. Receiver operating characteristic (ROC) curves of the second in the general population. These observations suggest that derivative of the finger photoplethysmogram indices for the discrimi- the SDPTG indices reflect the risk of CHD and that the nation of high-risk subjects for coronary heart disease in males (Top) measurement of these indices might be useful in terms of and in females (Bottom). The 95% confidence interval of the area cardiovascular preventive medicine. under the ROC curve (AUC) are shown in the parentheses. The b/a in Several investigators have studied the physiological both genders and the d/a in females revealed significant discrimina- tory performance. meanings and clinical implications of the SDPTG wave- form.19–21,25 The ‘b’ wave on the SDPTG mainly expresses the first vascular response to blood ejection from the left Coronary Risk Factors and SDPTG Indices in Each ventricle and no reflected components from the periphery Quintile interfere. Imanaga et al reported the relationship between The subjects who showed a Framingham risk score of the b/a and the distensibility of the carotid artery, suggest- 9 or more points in males (n=13) and 10 or more points in 25 ing that the b/a reflects the stiffness of large arteries. In females (n=17) were classified into the highest quintile and contrast, the ‘d’ wave mainly represents the intensity of the were considered to be high-risk subjects for CHD. The reflection wave from the periphery, which is determined by SDPTG indices and the coronary risk factors contributing the functional vascular tension and arteriolosclerosis in the to the calculation of the risk score (except for diabetes) in peripheral circulation, thus indicating vascular resistance. each quintile are listed in Table 3. Although TC and smok- Indeed, Takazawa et al reported that the d/a significantly ing did not show a difference in the quintiles, age, SBP, correlated with the aortic AIx, which partially suggests DBP, and HDLC in the lowest and/or second quintile(s) peripheral vascular resistance. 19,21,30 The d/a, therefore, were significantly lower (or higher) than those parameters might represent such vascular properties. in the highest quintile in both genders. In regard to the In the present study, the b/a was positively associated SDPTG indices, both the b/a and d/a in the lowest quintile with age whereas the d/a was inversely associated with in males and the lowest and second quintiles in females age. Aging increases both large arterial stiffness and vas- were significantly different from those in the highest quin- 31 cular resistance. These results, therefore, suggest that an tile. elevated b/a and a reduced d/a on the SDPTG reflect an increase in large arterial stiffness and peripheral vascular Discrimination of High-Risk Subjects for CHD resistance, respectively. In multivariate analyses, however, The ROC curves of the SDPTG indices to discriminate SBP was an independent determinant of the b/a, but not the the high-risk subjects in each gender are described in Fig 3. d/a. Moreover, gender was also an independent determi- The AUC of the b/a in males was 0.69 (95% CI: 0.54–0.84). nant of the b/a, whereas there was no relationship between Circulation Journal Vol.70, March 2006
  • 6. SDPTG and Risk of CHD 309 gender and the d/a, even in univariate analysis. Recently, Third, the number of subjects that participated in the pres- Hashimoto et al reported significant associations of both ent study was small for an epidemiological survey. In this SBP and gender with the d/a, as well as the b/a in the gen- regard, the smaller number of male participants might have 24 eral population. Although precise reasons for this in- resulted in a lower specificity of the b/a and the lack of consistency are not clear, one possibility is that the number discriminatory ability of the d/a, as well as the lack of asso- of subjects that participated in the present study was ciations between the SDPTG indices and the Framingham smaller than that in the study by Hashimoto et al. 24 risk score independent of age, in males. Regardless of these It is beyond doubt that a comprehensive risk assessment limitations, we believe that the present study deserves to in each individual for the future development of CHD is report as the first study, to our knowledge, concerning the important for the primary prevention of cardiovascular association between the SDPTG and the risk of CHD in the 32 disease. Therefore, the Framingham risk score has been general population. developed as one of the appropriate tools of the compre- In conclusion, the SDPTG indices significantly associ- hensive risk assessment of CHD in the USA. Recently,26 ated not only with several coronary risk factors, but also Suka et al reported that the incidence of CHD gradually with the Framingham risk score in subjects without appar- increased with an increase in the Framingham risk score in ent atherosclerotic disorders at the time of health examina- 33 the Japanese population. These observations indicate that tion. Furthermore, the b/a screened subjects at risk of CHD this score is applicable to the estimation of the individual’s with an acceptable sensitivity and specificity. These results CHD risk in Japan. Meanwhile, numerous studies have suggest that the measurement of SDPTG is useful for the reported that the pulse-wave velocity (PWV), AIx, and PP, estimation of the risk of CHD in the general population. all of which are major surrogate markers of arterial stiff- However, further studies with a larger number of partici- ness, are associated with cardiovascular risk4–11 and inde- pants are needed to confirm these results. pendently predict mortality and morbidity from CHD. 12–18 Furthermore, Yamashina et al recently showed that an Acknowledgments increased brachial-ankle PWV was an independent deter- We are thankful to Dr Masakazu Takahashi and the colleagues in our minant of moderate- to high-risk subjects for CHD based department for their cooperation in collecting the data. on the Framingham risk score in Japanese subjects. Their 4 report indicates an association between arterial stiffness References and the Framingham risk score in the Japanese population. 1. Health and Welfare Statistics Association. Trend of National Health. In the present study, the SDPTG indices significantly corre- Journal of Health and Welfare Statistics 2004; 51: 49 – 50 (in Japa- lated with the Framingham risk score. Moreover, there nese). were significant differences in the SDPTG indices in the 2. Egusa G, Yamane K. Lifestyle, serum lipids and coronary artery dis- highest and other quintiles of the Framingham risk score. ease: Comparison of Japan with the United States. J Atheroscler Thromb 2004; 11: 304 – 312. These findings suggest that the measurement of SDPTG 3. Imamura H, Izawa A, Kai R, Yokoseki O, Uchikawa S, Yazaki Y, et has utility for the assessment of an individual’s CHD risk in al. Trends over the last 20 years in the clinical background of young the general population in Japan. However, significant asso- Japanese patients with coronary artery disease. Circ J 2004; 68: ciations between the SDPTG indices and the Framingham 186 – 191. 4. Yamashina A, Tomiyama H, Arai T, Hirose K, Koji Y, Hirayama Y, risk score were observed independently of age in females, et al. Brachial-ankle pulse wave velocity as a marker of atherosclero- but not in males. These findings suggest that age is a con- tic vascular damage and cardiovascular risk. Hypertens Res 2003; founding factor for the correlations in males. This point 26: 615 – 622. should be evaluated more precisely in further studies. 5. Tomiyama H, Yamashina A, Arai T, Hirose K, Koji Y, Chikamori T, We were able to determine the optimal cut-off points of et al. Influences of age and gender on results of noninvasive brachial- ankle pulse wave velocity measurement – a survey of 12517 subjects. the b/a on the ROC curves to discriminate the high-risk Atherosclerosis 2003; 166: 303 – 309. subjects for CHD in our study population with a sensitivity 6. Taquet A, Bonithon-Kopp C, Simon A, Levenson J, Scarabin Y, of more than 0.8 in both genders and a specificity of more Malmejac A, et al. Relations of cardiovascular risk factors to aortic than 0.7 in females. However, the specificity of the b/a in pulse wave velocity in asymptomatic middle-aged women. Eur J Epidemiol 1993; 9: 298 – 306. males was lower than that in females. Reduced specificity 7. Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse indicates an increase in the number of false positives. How- wave velocity as a marker of cardiovascular risk in hypertensive pa- ever, false positives would, at first, be subjected to lifestyle tients. Hypertension 1999; 33: 1111 – 1117. modification in terms of the primary prevention of CHD. 32 8. Benetos A, Adamopoulos C, Bureau JM, Temmar M, Labat C, Bean K, et al. Determinants of accelerated progression of arterial stiffness Therefore, we believe that a higher number of false posi- in normotensive subjects and in treated hypertensive subjects over a tives with a specificity of 0.58 in males is acceptable, and 6-year period. Circulation 2002; 105: 1202 – 1207. the b/a could be used for screening subjects at risk of CHD 9. Hayashi T, Nakayama Y, Tsumura K, Yoshimaru K, Ueda H. Reflec- in the general population. In contrast, the d/a discriminated tion in the arterial system and the risk of coronary heart disease. Am J Hypertens 2002; 15: 405 – 409. high-risk females with a sensitivity and specificity of ap- 10. Nurnberger J, Keflioglu-Scheiber A, Opazo Saez AM, Wenzel RR, proximately 0.6 and it did not discriminate high-risk males. Philipp T, Schafers RF. Augmentation index is associated with car- These findings indicate that the d/a might be less useful for diovascular risk. J Hypertens 2002; 20: 2407 – 2414. screening subjects at risk for CHD in the general popula- 11. Weber T, Auer J, O’Rourke MF, Kvas E, Lassnig E, Berent R, et al. tion. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 2004; 109: 184 – 189. The present study has some limitations. First, none of 12. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et the subjects with diabetes participated in this study. Further al. Aortic stiffness is an independent predictor of all-cause and car- studies are needed in populations with glucose intolerance diovascular mortality in hypertensive patients. Hypertension 2001; similar to the average Japanese population. Second, this 37: 1236 – 1241. 13. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London study is not a longitudinal survey, but a cross-sectional sur- GM. Impact of aortic stiffness on survival in end-stage renal disease. vey. It is, therefore, still uncertain as to whether the SDPTG Circulation 1999; 99: 2434 – 2439. indices truly predict mortality and morbidity from CHD. 14. Meaume S, Benetos A, Henry OF, Rudnichi A, Safar ME. Aortic Circulation Journal Vol.70, March 2006
  • 7. 310 OTSUKA T et al. pulse wave velocity predicts cardiovascular mortality in subjects >70 photoplethysmogram in treated hypertensive patients: Their relation- years of age. Arterioscler Thromb Vasc Biol 2001; 21: 2046 – 2050. ship and associating factors. J Hypertens 2002; 20: 2415 – 2422. 15. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley 24. Hashimoto J, Watabe D, Kimura A, Takahashi H, Ohkubo T, Totsune P, et al. Aortic stiffness is an independent predictor of primary coro- K, et al. Determinants of the second derivative of the finger photo- nary events in hypertensive patients: A longitudinal study. Hyperten- plethysmogram and brachial-ankle pulse-wave velocity: The sion 2002; 39: 10 – 15. Ohasama study. Am J Hypertens 2005; 18: 477 – 485. 16. Shokawa T, Imazu M, Yamamoto H, Toyofuku M, Tasaki N, Okimoto 25. Imanaga I, Hara H, Koyanagi S, Tanaka K. Correlation between T, et al. Pulse wave velocity predicts cardiovascular mortality: Find- wave components of the second derivative of plethysmogram and ings from the Hawaii-Los Angeles-Hiroshima study. Circ J 2005; arterial distensibility. Jpn Heart J 1998; 39: 775 – 784. 69: 259 – 264. 26. Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, 17. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse Kannel WB. Prediction of coronary heart disease using risk factor pressure useful in predicting risk for coronary heart disease? The categories. Circulation 1998; 97: 1837 – 1847. Framingham heart study. Circulation 1999; 100: 354 – 360. 27. Jespersen LT, Pedersen OL. The quantitative aspect of photoplethys- 18. Domanski M, Norman J, Wolz M, Mitchell G, Pfeffer M. Cardiovas- mography revised. Heart Vessels 1986; 2: 186 – 190. cular risk assessment using pulse pressure in the first national health 28. Iketani Y, Iketani T, Takazawa K, Murata M. Second derivative of and nutrition examination survey (NHANES I). Hypertension 2001; photoplethysmogram in children and young people. Jpn Circ J 2000; 38: 793 – 797. 64: 110 – 116. 19. Takazawa K, Tanaka N, Fujita M, Matsuoka O, Saiki T, Aikawa M, 29. Bland JM, Altman DG. Statistical methods for assessing agreement et al. Assessment of vasoactive agents and vascular aging by the between two methods of clinical measurement. Lancet 1986; 1: 307 – second derivative of photoplethysmogram waveform. Hypertension 310. 1998; 32: 365 – 370. 30. Kelly RP, Millasseau SC, Ritter JM, Chowienczyk PJ. Vasoactive 20. Takada H, Washino K, Harrell JS, Iwata H. Acceleration plethysmo- drugs influence aortic augmentation index independently of pulse- graphy to evaluate aging effect in cardiovascular system: Using new wave velocity in healthy men. Hypertension 2001; 37: 1429 – 1433. criteria of four wave patterns. Med Prog Technol 1996; 21: 205 – 31. Ferrari AU, Radaelli A, Centola M. Invited review: Aging and the 210. cardiovascular system. J Appl Physiol 2003; 95: 2591 – 2597. 21. Takazawa K, Fujita M, Yabe K, Saiki T, Kobayashi T, Maeda K, et 32. Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann al. Clinical usefulness of the second derivative of a plethysmogram SP, et al. AHA Guidelines for Primary Prevention of Cardiovascular (acceleration plethysmogram). J Cardiol 1993; 23: 207 – 217. Disease and Stroke: 2002 Update: Consensus Panel Guide to Com- 22. Bortolotto LA, Blacher J, Kondo T, Takazawa K, Safar ME. Assess- prehensive Risk Reduction for Adult Patients Without Coronary or ment of vascular aging and atherosclerosis in hypertensive subjects: Other Atherosclerotic Vascular Diseases. Circulation 2002; 106: Second derivative of photoplethysmogram versus pulse wave veloci- 388 – 391. ty. Am J Hypertens 2000; 13: 165 – 171. 33. Suka M, Sugimori H, Yoshida K. Application of the updated Fram- 23. Hashimoto J, Chonan K, Aoki Y, Nishimura T, Ohkubo T, Hozawa ingham risk score to Japanese men. Hypertens Res 2001; 24: 685 – A, et al. Pulse wave velocity and the second derivative of the finger 689. Circulation Journal Vol.70, March 2006